Carroll M - Search Results

1

Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptor.

Bhattacharya S, Zheng H, Tzimas C, Carroll M, Baker DP, Fuchs SY. Bhattacharya S, et al. Among authors: carroll m. Blood. 2011 Oct 13;118(15):4179-87. doi: 10.1182/blood-2010-12-325373. Epub 2011 Aug 5. Blood. 2011. PMID: 21821707 Free PMC article.

2

TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle.

Dierov J, Xu Q, Dierova R, Carroll M. Dierov J, et al. Among authors: carroll m. Blood. 2002 Mar 1;99(5):1758-65. doi: 10.1182/blood.v99.5.1758. Blood. 2002. PMID: 11861293 Free article.

3

Survival of acute myeloid leukemia cells requires PI3 kinase activation.

Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M. Xu Q, et al. Among authors: carroll m. Blood. 2003 Aug 1;102(3):972-80. doi: 10.1182/blood-2002-11-3429. Epub 2003 Apr 17. Blood. 2003. PMID: 12702506 Free article.

4

BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint.

Dierov J, Dierova R, Carroll M. Dierov J, et al. Among authors: carroll m. Cancer Cell. 2004 Mar;5(3):275-85. doi: 10.1016/s1535-6108(04)00056-x. Cancer Cell. 2004. PMID: 15050919 Free article.

5

mTOR regulates cell survival after etoposide treatment in primary AML cells.

Xu Q, Thompson JE, Carroll M. Xu Q, et al. Among authors: carroll m. Blood. 2005 Dec 15;106(13):4261-8. doi: 10.1182/blood-2004-11-4468. Epub 2005 Sep 8. Blood. 2005. PMID: 16150937 Free PMC article.

6

The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.

Teachey DT, Obzut DA, Cooperman J, Fang J, Carroll M, Choi JK, Houghton PJ, Brown VI, Grupp SA. Teachey DT, et al. Among authors: carroll m. Blood. 2006 Feb 1;107(3):1149-55. doi: 10.1182/blood-2005-05-1935. Epub 2005 Sep 29. Blood. 2006. PMID: 16195324 Free PMC article.

7

p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.

Yu D, Carroll M, Thomas-Tikhonenko A. Yu D, et al. Among authors: carroll m. Blood. 2007 Jun 1;109(11):4936-43. doi: 10.1182/blood-2006-10-050294. Epub 2007 Feb 6. Blood. 2007. PMID: 17284530 Free PMC article.

8

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.

Hexner EO, Serdikoff C, Jan M, Swider CR, Robinson C, Yang S, Angeles T, Emerson SG, Carroll M, Ruggeri B, Dobrzanski P. Hexner EO, et al. Among authors: carroll m. Blood. 2008 Jun 15;111(12):5663-71. doi: 10.1182/blood-2007-04-083402. Epub 2007 Nov 5. Blood. 2008. PMID: 17984313 Free PMC article.

9

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

Teachey DT, Sheen C, Hall J, Ryan T, Brown VI, Fish J, Reid GS, Seif AE, Norris R, Chang YJ, Carroll M, Grupp SA. Teachey DT, et al. Among authors: carroll m. Blood. 2008 Sep 1;112(5):2020-3. doi: 10.1182/blood-2008-02-137141. Epub 2008 Jun 10. Blood. 2008. PMID: 18544682 Free PMC article.

10

BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold.

Dierov J, Sanchez PV, Burke BA, Padilla-Nash H, Putt ME, Ried T, Carroll M. Dierov J, et al. Among authors: carroll m. Leukemia. 2009 Feb;23(2):279-86. doi: 10.1038/leu.2008.308. Epub 2008 Nov 20. Leukemia. 2009. PMID: 19020542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,569 results

Search Page

Filters